Table 3.
Adrenaline group (n=46) | Dopexamine group (n=46) | Control group (n=46) | |
---|---|---|---|
No of patients surviving | 45 | 44 | 38 |
Hospital survival (%; 95% CI) | 98 (94 to 100) | 96 (90 to 100) | 83 (72 to 94) |
Combined treatment groups: 97 (93 to 100)* | |||
Actual mortality (%) | 2 | 4 | 17 |
Predicted mortality (%) | 12 | 15 | 13 |
Standardised mortality ratio (95% CI) | 0.19 (0.00 to 1.05) | 0.28 (0.04 to 1.08) | 1.36 (0.6 to 2.75) |
Fisher’s test for combined treatment groups v control, P=0.007.